NO985518L - Morfinanderivater og medisinsk anvendelse derav - Google Patents

Morfinanderivater og medisinsk anvendelse derav

Info

Publication number
NO985518L
NO985518L NO985518A NO985518A NO985518L NO 985518 L NO985518 L NO 985518L NO 985518 A NO985518 A NO 985518A NO 985518 A NO985518 A NO 985518A NO 985518 L NO985518 L NO 985518L
Authority
NO
Norway
Prior art keywords
medical use
morphine derivatives
morphinan derivatives
opioid
epsilon
Prior art date
Application number
NO985518A
Other languages
English (en)
Norwegian (no)
Other versions
NO985518D0 (no
Inventor
Hiroshi Nagase
Hideaki Fujii
Takashi Endoh
Koji Kawai
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO985518D0 publication Critical patent/NO985518D0/no
Publication of NO985518L publication Critical patent/NO985518L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO985518A 1997-03-27 1998-11-26 Morfinanderivater og medisinsk anvendelse derav NO985518L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7634097 1997-03-27
PCT/JP1998/001376 WO1998043978A1 (fr) 1997-03-27 1998-03-27 Derives de morphinane et usage medical de ces derniers

Publications (2)

Publication Number Publication Date
NO985518D0 NO985518D0 (no) 1998-11-26
NO985518L true NO985518L (no) 1999-01-21

Family

ID=13602637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985518A NO985518L (no) 1997-03-27 1998-11-26 Morfinanderivater og medisinsk anvendelse derav

Country Status (12)

Country Link
US (1) US6187782B1 (fr)
EP (1) EP0915094B1 (fr)
KR (1) KR20000016052A (fr)
CN (1) CN1150196C (fr)
AT (1) ATE377602T1 (fr)
AU (1) AU743929B2 (fr)
CA (1) CA2256897C (fr)
DE (1) DE69838662T2 (fr)
ES (1) ES2297882T3 (fr)
NO (1) NO985518L (fr)
NZ (1) NZ333101A (fr)
WO (1) WO1998043978A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039444D1 (de) * 1999-08-24 2008-08-21 Toray Industries Heilmittel für neuropathischen schmerz und versuchstier-modelle des neuropathischen schmerzes
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
AU2007313103C1 (en) * 2006-10-17 2014-01-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
CA2674915C (fr) * 2006-10-17 2015-06-30 Penick Corporation Procede servant a preparer de l'oxymorphone
AU2008247818B2 (en) 2007-05-01 2011-10-20 Sun Pharmaceutical Industries, Inc. Morphinan compounds
MX385316B (es) 2007-05-01 2025-03-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
WO2009149347A1 (fr) 2008-06-05 2009-12-10 President And Fellows Of Harvard College Complexes de fluorure de palladium de valence élevée et leurs utilisations
CN102196811B (zh) * 2008-10-24 2014-03-19 东丽株式会社 含有4,5-环氧基吗啡烷衍生物的稳定片剂
WO2010059943A2 (fr) 2008-11-20 2010-05-27 President And Fellows Of Harvard College Fluoration de composés organiques
KR20110104097A (ko) * 2009-01-09 2011-09-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 불소 함유 화합물 및 이의 사용방법
JP2014073964A (ja) * 2011-01-28 2014-04-24 Kitasato Institute モルヒナン誘導体
EP2697204B1 (fr) 2011-04-12 2017-03-08 President and Fellows of Harvard College Fluoration de composés organiques
HUE032470T2 (en) * 2011-09-09 2017-09-28 The Kitasato Inst Morphinan derivative
WO2014021273A1 (fr) * 2012-07-30 2014-02-06 学校法人北里研究所 Dérivés morphinane
WO2014052622A1 (fr) 2012-09-26 2014-04-03 President And Fellows Of Harvard College Complexes de fluoration de nickel et leurs utilisations
CA2896919C (fr) 2012-12-31 2019-01-29 Rhodes Technologies Procede pour la preparation d'etheno-6.alpha.,14.alpha.-morphinanes a substitution 7.beta. et d'ethano-6.alpha.,14.alpha.morphinanes a substitution 7.beta.
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
US10759764B2 (en) 2013-10-18 2020-09-01 President And Fellows Of Harvard College Fluorination of organic compounds
JP6814470B2 (ja) * 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
WO2019045006A1 (fr) * 2017-08-31 2019-03-07 日本ケミファ株式会社 Dérivé de morphinane
WO2019168025A1 (fr) * 2018-02-28 2019-09-06 日本ケミファ株式会社 Procédé de production de dérivés de morphinane
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
ZA855058B (en) * 1984-07-05 1987-03-25 Du Pont Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans,intermediates thereto,and processes
PT95069B (pt) * 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
US6323212B1 (en) 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications

Also Published As

Publication number Publication date
NZ333101A (en) 2000-05-26
DE69838662D1 (de) 2007-12-20
WO1998043978A1 (fr) 1998-10-08
CN1150196C (zh) 2004-05-19
CA2256897C (fr) 2006-10-03
ATE377602T1 (de) 2007-11-15
DE69838662T2 (de) 2008-08-28
KR20000016052A (ko) 2000-03-25
AU6518998A (en) 1998-10-22
NO985518D0 (no) 1998-11-26
CA2256897A1 (fr) 1998-10-08
US6187782B1 (en) 2001-02-13
EP0915094B1 (fr) 2007-11-07
EP0915094A1 (fr) 1999-05-12
AU743929B2 (en) 2002-02-07
EP0915094A4 (fr) 2004-09-22
ES2297882T3 (es) 2008-05-01
CN1220667A (zh) 1999-06-23

Similar Documents

Publication Publication Date Title
NO985518D0 (no) Morfinanderivater og medisinsk anvendelse derav
ATE212978T1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
JO2371B1 (en) 4-phenyl-pyridine derivatives
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
BR0312934A (pt) Derivados de 8-hidróxi quinolina
EA200500814A1 (ru) Производные пирролопиримидина
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
DK1543010T3 (da) N-substituerede hydromorphoner og anvendelse deraf
MY146279A (en) Compounds affecting glucokinase
EA200400467A1 (ru) Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
ATE352543T1 (de) Ein dioxino(2,3-g)chinolin-9-carbonsäure derivat als nk3 rezeptor antagonist
DE60302157D1 (de) Opioidrezeptorantagonisten
DE69935670D1 (de) Behandlung von dyskinesie durch mu-selektive opioidantagonisten
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
DE69429328D1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
EA200301120A1 (ru) Цитрат 5,8,14-триазатетрацикло (10.3.1.0.0)-гексадека-2 (11),3,5,7,9-пентаена
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
ATE414516T1 (de) Morphinanderivate als mittel gegen juckreiz
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина